Search
for
Sort by
Research 481–510 of 1000+
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- 578 Addressing the missing components for appropriate surveillance of Merkel cell carcinoma patients: Detailed recurrence data and an integrated risk analysis approach
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case–control study
- Comments on “ Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study ”
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Chronic telogen effluvium in Egyptian children: Analysis of common risk factors
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Association of Spironolactone Use With Risk of Cancer
- Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents
- The risk of coronary heart disease in men with androgenetic alopecia
- Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis
- Androgenetic alopecia and risk of coronary artery disease
- Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia
- Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study
- Risk factors and lipid metabolism characteristics of early‐onset male androgenetic alopecia: A pilot study
- The risk of coronary heart disease in men with androgenetic alopecia
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Acne keloidalis nuchae: risk factors and associated disorders – a retrospective study
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: a retrospective cohort database study
- Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
- An overview of risk factors for androgenetic alopecia among women at Pasar Ambacang, Kuranji, Padang